European Health
Information
Gateway

Home
Gateway
Country profiles
Data
Indicators Explorer
Databases
European Health for All database (HFA-DB) European Programme of Work Digital Health Rehabilitation Health-enhancing physical activity European mortality database (MDB) European database on human and technical resources for health (HlthRes-DB) Environment and Health Information System (ENHIS) Financial protection in the European Region
Monitoring
Child and adolescent health Seasonal influenza vaccination policies and coverage
Reporting
Health Behaviour in School-aged Children (HBSC) Maternal nutrition, physical activity and weight gain during pregnancy Antimicrobial resistance Global nutrition policy survey Status of child and adolescent health policies in Europe
Archive
Health 2020 indicators Global eHealth survey 2015 Joint Monitoring Framework (JMF)

Public pharmaceutical expenditure as % of total pharmaceutical expenditure

Indicator full name: Public pharmaceutical expenditure as % of total pharmaceutical expenditure

Unit: %

Dimensions:

  • Country/Area (COUNTRY/AREA)
  • Supranational group of countries (COUNTRY_GRP)
  • Sex (SEX)
  • Year of measure (YEAR)

Years data is available: 1970—2022

Indicator is part of data set(s):

Last updated: 07 October 2024

Export to:
Countries with no data (10): 
  • Albania
  • Andorra
  • Armenia
  • Bulgaria
  • Georgia
  • Monaco
  • Montenegro
  • North Macedonia
  • Romania
  • Turkmenistan
(Sub)regional averages available for: 
  • Commonwealth of Independent States
  • Central Asian Republics Information Network members (CARINFONET)
  • South-eastern Europe Health Network members (SEEHN)
  • Western Balkans
View in Indicators Explorer

Explore this indicator's data in a specialized tool

Related indicators in HFA-DB
You might be interested in as well
Datasets
Back to preview
  • Public pharmaceutical expenditure as % of total pharmaceutical expenditure Public pharmaceutical expenditure as % of total pharmaceutical expenditure (Line chart)
  • Public pharmaceutical expenditure as % of total pharmaceutical expenditure Public pharmaceutical expenditure as % of total pharmaceutical expenditure (Bar chart)
  • Public pharmaceutical expenditure as % of total pharmaceutical expenditure Public pharmaceutical expenditure as % of total pharmaceutical expenditure (Boxplot chart)
See full graph
Back to preview
Data set notes
European Health for All database

Indicators: 565
Updated: 18 October 2024

The following abbreviations are used in the indicator titles:
•    SDR: age-standardized death rates (see HFA-DB user manual/Technical notes, page 13, for details)
•    FTE: full-time equivalent
•    PP: physical persons
•    PPP$: purchasing power parities expressed in US $, an internationally comparable scale reflecting the relative domestic purchasing powers of currencies.

Indicator notes
Public pharmaceutical expenditure as % of total pharmaceutical expenditure
Indicator code: E992709.T

The publicly financed share of total pharmaceutical expenditure. See 992708 above.

The OECD Health Database is used as the primary data source for those countries that are OECD Member States._
Country/Area notes
Albania
Ministry of Health. Health insurance institute.
Armenia
Data are not available.
Austria
Expenditure on pharmaceuticals includes expenditure on other medical non-durables (corresponds to
ICHA-HC.5.1).
Belgium
Source: National Institute for Health Insurance / calculations made by the Federal Public Service
Social Security.
Bosnia and Herzegovina
National Health Account of B&H; http://www.who.int/nha/country/bih/en/ Ministry of Civil Affairs of
B&H, Health Insurance Fund of Federation of B&H; Health Insurance Fund of Republic of Srpska;
Department for Health of Brcko District
Cyprus
No data are available
Czechia
Source: Czech Statistical Office, Czech Health Accounts.
Denmark
Source: OECD health database (www.stats.oecd.org).
Estonia
Source: up to 1997 State Statistical Office. From 1998 National Institute for Health Development.
Pharmaceuticals consumed in hospitals are excluded.
Estonia has provided public pharmaceutical expenditure as % of total pharmaceutical expenditure data
for year 2009-2014.
Finland
Source: Social Insurance Institute
Germany
Source: Federal Statistical Office, Health Expenditure Accounts.
http://www.gbe-bund.de
Greece
For years 2009 to 2014 data are provided according to the system of Health Accounts (SHA 2011)
Methodology. GDP estimates refer to ESA 2010 Methodology
Iceland
Source: National Economic Institute.
Israel
Since 2000, is based on updated OECD definitions.
Source: National Accounts, Central Bureau of Statistics.
Italy
Source: Istat, National accounts. The OECD definition is applied.
Data for the period 1992-2012 have been estimated on the basis of the updated version of the
classification of economic activities (Ateco 2007, the national version of Nace Rev. 2) and of
products by activity (CPA 2008) and are consistent with the revised time series of national
accounts.
Lithuania
Source: from 2004 onwards: Central Statistical Office. HC.5.1 x HF.1 data according to OECD SHA
methodology. Since 2013 methodology of SHA2011 is used.
Deviation from the definition: Since 2013 current expenditure on health care is used instead of
total health expenditure.
Malta
Source: National Statistics Office (data reviewed from 2001).
Montenegro
Data are not available.
Netherlands
Source of data: Statistics Netherlands: 1972-1997 data: Cost and financing of health care. 1998-
onwards: Health and social care accounts.
Note: The sudden increases and decreases in trend are due to changes in the financing system.
Portugal
Source of data: National Statistical Institute/OECD Coverage: National
Republic of Moldova
Starting from 2010 calculation of health financing indicators is based on the National Health
Accounts.
Romania
Data are not available.
Serbia
Source of data: NHA data. NHA data received from HIF (Health Insurance Fund)and Drug Agency.
Slovenia
Source of data: Statistical Office of the Republic of Slovenia.
Turkmenistan
Data are not available.
United Kingdom
Coverage: Data refers to England only.
Deviation from the Definition: Data as at 31st December.